Nasal Spray Recalled Due to Microbial Growth Risks and Infection Concerns

MPL Laboratories provides microbial, sterility and shelf-life testing services for over-the-counter medicines, pharmaceuticals, personal care products, cosmetics and consumer goods at its FDA registered and DEA licensed testing facility.

Sparta, NJ, September 12, 2023  Health Canada published an advisory in July detailing the recall of one lot of an over-the-counter (OTC) nasal spray due to a risk of microbial growth in the product. The recall warns that testing found that the preservative in the product may not be as effective as expected. This could lead to an increased risk of the growth of microbes, such as mold or bacteria, if they are introduced into the product over time.   Using a nasal spray that is contaminated with microbes may result in a sinus.......[Read More] [All News]

Upscale Day Cream Recalled Due to Microbial Contamination Concerns

MPL Laboratories provides USP microbial and sterility testing services for cosmetics, over-the-counter (OTC) medicines, pharmaceuticals and personal care products at its FDA registered, cGMP and ISO 17025 compliant testing facility.

Sparta, NJ, August 23, 2023  Last month, Health Canada announced the recall of three specific lots of a day cream that was distributed throughout the country from March to July of this year. The affected products were manufactured in Canada and packaged in cylindrical glass jars. 3138 units and 1559 affected samples were sold or distributed.   According to Health Canada: The recalled product does not meet microbial standards over time. The product may contain a microorganism called Streptococcus.......[Read More] [All News]

Skin Care Serum Recalled Due to Microbial Contamination Concerns

MPL Laboratories provides microbial and sterility testing services for personal care products, cosmetics, pharmaceuticals and consumer goods at its FDA registered, cGMP and ISO 17025 compliant testing facility.

Sparta, NJ, July 31, 2023  Last month, Health Canada posted information about the voluntary recall of two lots of Brightening Face Serum. The product was manufactured in Canada and sold in the country from February through May of this year.  According to the Health Canada notice: The recalled products may contain a common microorganism called Pseudomonas luteola. Pseudomonas luteola is an environmental organism found widely in soil and water. People with weakened immune systems, external medical devices, or.......[Read More] [All News]

CDC Reports Additional Infections and another Death Linked to Contaminated Eye Drops

MPL Laboratories provides microbial and sterility testing services for over-the-counter medicines, pharmaceuticals, cosmetics and personal care products at its FDA registered, cGMP and ISO 17025 compliant testing facility.

Sparta, New Jersey, July 17, 2023 Last month, the Centers for Disease Control and Prevention (CDC) reported 6 more cases of vision loss and one additional death linked to eye drops that were recalled earlier this year. The outbreak, involving a rare strain of extensively drug-resistant Pseudomonas aeruginosa, now totals 81 patients in 18 states according to the CDC. A total of 14 patients have had vision loss, an additional 4 patients have had eyeballs surgically removed, and there have been 4 deaths. Back in January, CDC first announced.......[Read More] [All News]

FDA Warns Consumers Not to Use Certain COVID-19 At-Home Tests Due to Bacterial Contamination Concerns

MPL Laboratories provides microbial and sterility testing services for test kits, over-the-counter (OTC) medicines, pharmaceuticals, cosmetics and other consumer products to protect the public and to help prevent costly recalls.

Sparta, New Jersey, July 13, 2023  Last month, the U.S. Food & Drug Administration (FDA) warned consumers and health care providers to stop using and throw out certain lots of a brand of COVID-19 at-home test kits. The FDA reported the agency has significant concerns of bacterial contamination in the liquid buffer solution that is provided in the test kit. The company that manufactured the kits has also warned consumers not to use them and announced a recall of over 500,000 test kits.  According to the FDA, the liquid.......[Read More] [All News]

Voluntary Recall of Marijuana Products in Arizona Due to Potential Aspergillus Contamination

MPL Laboratories provides cGMP and ISO 17025 compliant testing services to identify microbial contaminants in over-the-counter (OTC) medicines, pharmaceuticals, cosmetics and other consumer products.

Sparta, New Jersey, July 7, 2023 The Arizona Department of Health Services (ADHS) recently announced that several marijuana establishments were voluntarily recalling specific products due to possible contamination with a type of fungus known as Aspergillus. Five different products from four cultivators are involved in the recall. According to ADHS, the five products were found in laboratory tests to be positive for Aspergillus. Fortunately, the agency also shared that at the time of the recall, no illnesses had been reported. ADHS has.......[Read More] [All News]

Atovaquone Oral Suspension Recalled Due to Potential Microbial Contamination

MPL Laboratories provides cGMP and ISO 17025 compliant microbial and sterility testing services for pharmaceuticals, over-the-counter medicines, cosmetics and other consumer products.

Sparta, New Jersey, July 5, 2023  The U.S. Food & Drug Administration (FDA) recently posted information about the recall of an atovaquone oral suspension by a pharmaceutical company that specializes in generic drugs and over-the-counter (OTC) medications. The oral suspension is being recalled due to potential contamination with a Gram-positive bacterium known as Bacillus cereus.  Atovaquone is an antimicrobial medication used for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP). One lot of the product,.......[Read More] [All News]

CDC Investigates Multistate Cluster of Infections Potentially Linked to Eye Drops

MPL Laboratories provides microbial testing services for over-the-counter medicines, pharmaceuticals, cosmetics, personal care products and consumer goods at its FDA registered, cGMP and ISO 17025 compliant testing facility.

Sparta, New Jersey, February 16, 2023 Last week, the Centers for Disease Control and Prevention (CDC) confirmed it is collaborating with the Food and Drug Administration (FDA) and state and local health departments to investigate a multistate outbreak of an extensively drug-resistant strain of Pseudomonas aeruginosa. The outbreak strain, which has never been reported in the United States prior to this outbreak, was carbapenem-resistant Pseudomonas aeruginosa with Verona integron-mediated metallo-β-lactamase and.......[Read More] [All News]